Digital Health
Digital health breakthroughs happen with Cooley.
Practices
-
700+digital health companies represented by Cooley as they improve the quality and affordability of healthcare1,700+private financings handled annually, with $9.2 billion in aggregate digital health transactions in 2024#1IPO firm for 15 years, representing more VC-backed initial public offerings than any other firm, according to IPO Vital Signs29%Nearly a third of US-based unicorns are represented by CooleyAccess to an unparalleled network of active digital health investors and thought leadersLawyers who are widely recognized for thought leadership in the digital health space, including delivery of keynotes for the BIO International Convention’s digital health and artificial intelligence (AI) tracks and the Digital Health Innovation Summit Litigation
-
85+trials and arbitrations across global venues in the past 10 years100+venues argued before, including state, federal and international courts, arbitral forums and administrative bodies5Fellows of the American College of Trial Lawyers and 20+ former assistant US attorneys and Department of Justice lawyers within our team60+mentions in The American Lawyer’s Litigation Daily Litigator of the Week since 2022Frequently litigating landmark, precedent-setting cases that establish industrywide resolutions or new procedural protections for our clientsDefending clients against False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies and other Food, Drug, and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state, and federal civil and criminal government enforcers
-
Leveraging strong US and global experience to provide regulatory counseling and advice on the Food and Drug Administration, fraud and abuse, corporate compliance, contractual relationships, transparency and “sunshine” laws, government program price reporting programs, healthcare data privacy and protection, licensure, accreditation, corporate practice of medicine, health reform counseling, regulatory due diligences, the UK Medicines and Healthcare Regulatory Agency (MHRA) and CE markingAdvising all players in the evolving ecosystem, including healthtech, health artificial intelligence (AI), population health management, health and wellness, payers, providers, life sciences companies, health IT and investorsServing as connectors to the digital health ecosystem who counsel clients on how to launch innovative products and servicesUsing vast subject matter knowledge and litigation and negotiation experience to represent healthcare clients in connection with federal and state government investigations, inquiries, settlements, and voluntary disclosuresOffering a multidisciplinary team of industry-leading lawyers who provide counsel related to privacy and data protection, government contracts, and government analyticsContributing frequently on groundbreaking regulatory topics at high-profile industry events, on editorial boards, and in relevant media and publicationsMarket leader in life sciences – #1 in IPOs, M&A transactions, venture financings and licensingProviding comprehensive and timely guidance through CooleyREG, our innovative approach that brings together regulatory practitioners from across the firm to help clients navigate every regulatory twist and turn
-
1,000+investor-side and company-side patent due diligence reviews in M&A deals, capital market offerings, financings and other high-value transactions450+US patent, trademark and copyright district court cases handled since 201970,000+patents and trademarks under Cooley management globally
Life Sciences & Healthcare Innovation Hub
Comprehensive resource for key stakeholders across the global life sciences and healthcare industry
Digital health and AI tracks at BIO International Convention
Cooley has helped organize the digital health track at BIO since it first launched in 2014, highlighting digital health’s role in all phases of healthcare, from drug discovery, home health and precision medicine to consumer health and healthcare workflow and interoperability platforms.
AI Talks Series: AI + Digital Health
AI has the potential to revolutionize our healthcare system, from drug discovery and development to diagnostic platforms and clinical workflow applications that elevate patient care and improve outcomes. Watch an on-demand recording of this webinar session covering the opportunities and challenges for digital health companies leveraging AI capabilities.
Cooley Healthtech Conference
Top healthtech industry executives, investors, entrepreneurs and thought leaders gathered to discuss key drivers affecting the industry, as well as explore growth strategies for healthtech, medical device, medtech and digital health companies.
Group contacts

